As per the attachment.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cian Healthcare Ltd has received two key approvals from BSE dated March 10, 2026, as part of implementing the Resolution Plan approved by the NCLT Mumbai Bench on December 18, 2025 under the Insolvency and Bankruptcy Code. BSE has granted in-principle approval for the issuance of 2,37,50,000 new equity shares (face value INR 10) to three prospective promoters — Ananta Medicare Limited (55%), Rajesh Jain (21%), and Mr. Pradeep Kumar Jain (19%) — together taking 95% promoter holding. Separately, BSE has also approved the listing of 12,50,000 equity shares (distinctive numbers 01 to 12,50,000) allotted to public shareholders in line with the approved resolution plan. The new shares will rank pari-passu with existing equity shares, and the company will proceed with allotment and demat credit upon completing the required compliance formalities.
Existing public shareholders will face massive dilution as the new promoter group takes 95% control of the company, effectively a change in management following the insolvency resolution. Minority shareholders should expect heightened stock volatility, potential exit challenges due to reduced free float, and should monitor for any further disclosures on the company's post-resolution business plans.